Clinical features of nivolumab-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: retrospective analysis based on case reports
As a rare immune-related adverse event of nivolumab, SJS/TEN should be closely monitored during the treatment. Nivolumab induced SJS/TEN has a long incubation period, serious clinical symptoms and poor prognosis.
Authors
- Ronghui Li (ORCID: https://orcid.org/0009-0004-5107-973X)
- Chunjiang Wang (ORCID: https://orcid.org/0000-0002-8490-0131)
- Xiang Liu (ORCID: https://orcid.org/0009-0008-9958-745X)
- Haibo Lei (ORCID: https://orcid.org/0009-0002-0221-5286)
Institutions
- Central South University (CN)
- Hunan University (CN)
- Xiangyang Central Hospital (CN)
- Third Xiangya Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-03-18
- DOI
- https://doi.org/10.3389/fimmu.2025.1563100
- Citations
- 2
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 2.79